While 340B ESP provides an avenue to assist Covered Entities in regaining access to 340B medications to continue supporting underserved patients, the complexity and timeliness issues inherent in 340B ESP have created many new challenges.
Managing compliance while also optimizing program performance and ensuring continued revenue success are essential to a robust 340B Program, even more as a result of the hits that CEs have taken as a result of manufacturers refusal to provide 340B prices for contract pharmacy over the past two years.
Visante’s 340B consulting practice has successfully supported dozens of clients with various aspects of 340B ESP submission and revenue recovery and has developed a unique approach to best support our clients’ needs. Kristin Fox-Smith, Managing Director, and Angela De Ianni, Senior director, will present 5 practical tips to navigate 340B ESP and optimize your program performance:
Topics to cover:
Visante is a specialized consulting firm focused on helping health systems accelerate strong financial and operational performance through pharmacy. Our team of professionals brings deep, contemporary expertise and innovation to optimizing all aspects of a fully integrated health system pharmacy program, driving significant value quickly. By providing customized solutions to fit the needs of our clients, we deliver sustained financial results through revenue growth, cost savings, assured compliance and optimal business performance. Learn more at visanteinc.com.